Dongsung Pharm (002210) — Cash Flow Quality Index

Latest as of March 2023: -1.00x

Dongsung Pharm (002210) has a Cash Flow Quality Index of -1.00x as of March 2023. Operating cash flow of ₩-771.02 Million is below net income of ₩771.59 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Dongsung Pharm (002210) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-1.00x
Operating CF / Net Income

Operating Cash Flow

₩-771.02 Million
KRW

Net Income

₩771.59 Million
KRW

Data as of

Mar 2023
Most recent filing

Dongsung Pharm Cash Flow Quality Index (2008–2011)

Historical Cash Flow Quality Index for Dongsung Pharm across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Dongsung Pharm.

Annual Cash Flow Quality Index for Dongsung Pharm (2008–2011)

Year-by-year earnings quality comparison for Dongsung Pharm.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2011 -1.55x ₩-2.64 Billion ₩1.70 Billion ▲ +82.4%
2009 -8.83x ₩-5.02 Billion ₩568.43 Million ▼ -8742.7%
2008 -0.10x ₩-365.26 Million ₩3.66 Billion
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.